When people can access diverse #contraceptive options, they are more likely to find one that matches their preferences and needs. DMPA-SC self-injection is that option for many women and girls: 13 countries reported 1 million+ visits for self-injection from 2018 to 2022. Building on that momentum, we are launching a new phase of work to increase #FamilyPlanning access and options through #DMPASC and #SelfInjection. The Injectables Access Collaborative is led by PATH with an expanded consortium: Clinton Health Access Initiative, Inc., inSupply Health, Jhpiego, & JSI. #SelfCare4UHC https://lnkd.in/dp9bf3xr
